Sometimes the best depot performance comes from challenging operational environments.

Sometimes the best depot performance comes from challenging operational environments.

Ukraine's H1 2025 numbers: 295 active trials, 33 new international protocols approved, 373 regulatory applications processed.

At COREX, our Ukraine operations have quietly become a network standout. While industry players debate market strategies, we've been building something sustainable here.

"The fundamentals speak for themselves," says Mark Woolf, COO at COREX. "312 GCP-trained professionals, continued EU harmonization meetings, 97 comprehensive safety reports processed in six months. When you invest in local expertise and understand regional dynamics, challenging circumstances often reveal your operational strengths."

Our Ukraine depot consistently exceeds European benchmarks. This isn't about chasing headlines—it's about recognizing where your team delivers exceptional value.

Questions about our Ukraine operations? Happy to share insights.

#ClinicalTrials #PharmaLogistics #EuropeanMarkets #SupplyChain #BioPharma

Back to the list